-
Real Time Chart
-
Stock Profile
-
Stock Fundamentals
Financials As Reported
-
accession Number
0001193125-23-140697
-
accounts Receivable Net Current
3,435,000,000
-
accumulated Other Comprehensive Income Loss Net Of Tax
--2,701,000,000
-
amendment Flag
false
-
assets
43,456,000,000
-
assets Current
11,501,000,000
-
cash And Cash Equivalents At Carrying Value
2,143,000,000
-
cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
2,176,000,000
-
cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
--658,000,000
-
cik
818,686
-
city Area Code
+972 (3)
-
common Stock Par Or Stated Value Per Share
0.1
-
common Stock Shares Authorized
2,495,000,000
-
common Stock Shares Issued
1,226,000,000
-
comprehensive Income Net Of Tax
--69,000,000
-
cost Of Goods And Services Sold
2,079,000,000
-
current Fiscal Year End Date
--12-31
-
date Filed
2023-05-10
-
document Fiscal Period Focus
Q1
-
document Fiscal Year Focus
2,023
-
document Period End Date
2023-03-31
-
document Transition Report
false
-
document Type
10-Q
-
earnings Per Share Basic
-0.18
-
earnings Per Share Diluted
-0.18
-
entity Address Address Line 1
124 Dvora HaNevi’a St.
-
entity Address City Or Town
Tel Aviv
-
entity Address Postal Zip Code
6,944,020
-
entity Central Index Key
818,686
-
entity Current Reporting Status
Yes
-
entity Emerging Growth Company
false
-
entity File Number
001-16174
-
entity Filer Category
Large Accelerated Filer
-
entity Incorporation State Country Code
L3
-
entity Interactive Data Current
Yes
-
entity Name
TEVA PHARMACEUTICAL INDUSTRIES LTD
-
entity Registrant Name
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
-
entity Shell Company
false
-
entity Small Business
false
-
entity Tax Identification Number
00-0000000
-
gross Profit
1,582,000,000
-
income Tax Expense Benefit
--19,000,000
-
inventory Net
4,118,000,000
-
irs Number
0
-
liabilities
34,844,000,000
-
liabilities And Stockholders Equity
43,456,000,000
-
liabilities Current
10,411,000,000
-
liabilities Noncurrent
24,433,000,000
-
local Phone Number
914-8213
-
long Term Debt Current
1,000,000,000
-
net Cash Provided By Used In Financing Activities
--706,000,000
-
net Cash Provided By Used In Investing Activities
181,000,000
-
net Cash Provided By Used In Operating Activities
--145,000,000
-
net Income Loss
--205,000,000
-
nonoperating Income Expense
--260,000,000
-
operating Income Loss
2,000,000
-
operating Lease Liability Noncurrent
345,000,000
-
operating Lease Right Of Use Asset
420,000,000
-
other Assets Current
542,000,000
-
other Assets Noncurrent
450,000,000
-
other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
120,000,000
-
other Liabilities Current
1,000,000,000
-
other Liabilities Noncurrent
3,869,000,000
-
payments For Proceeds From Other Investing Activities
1,000,000
-
payments To Acquire Businesses Net Of Cash Acquired
0
-
payments To Acquire Property Plant And Equipment
139,000,000
-
period End
1,680,220,800,000
-
period Start
1,672,531,200,000
-
proceeds From Payments For Other Financing Activities
--5,000,000
-
property Plant And Equipment Net
5,751,000,000
-
repayments Of Long Term Debt
3,152,000,000
-
report Link
https://www.sec.gov/Archives/edgar/data/818686/000119312523140697/d464631d10q_htm.xml
-
retained Earnings Accumulated Deficit
--13,086,000,000
-
revenue From Contract With Customer Excluding Assessed Tax
3,661,000,000
-
share Based Compensation
32,000,000
-
stockholders Equity
7,860,000,000
-
trading Symbol
TEVA
-
update
1970-01-01
-
weighted Average Number Diluted Shares Outstanding Adjustment
1,115,000,000
-
weighted Average Number Of Diluted Shares Outstanding
1,115,000,000
-
weighted Average Number Of Shares Outstanding Basic
1,115,000,000
-
id
REPORTED_FINANCIALS
-
key
TEVA
-
subkey
10-Q
-
date
2023-05-10
-
updated
2023-05-11
-
Symbol Info
-
Symbol Over View
-
Technical Analysis
TEVA stock fundamentals - financials as reported